|
|
 | | | |
- close
- close
- close
- close
Alnylam Pharma (MUC:DUL) |
Benzinga
Jan 30
Comment
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, and collaborators announced today the publication of complete study
results from a Phase I trial with ALN-VSP, a systemically delivered RNAi
therapeutic for the...
Benzinga
Jan 16
Comment
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics
company, today announced that the underwriters of its previously announced
public offering of common stock have exercised their option to purchase an
additional 1,200,000...
Benzinga
Jan 14
Comment
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics
company, today announced that it has commenced an underwritten public offering
of shares of its common stock to raise aggregate proceeds of approximately
$125 million. All...
Benzinga
Nov 26
Comment
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, announced today that the United States Patent and Trademark Office
(USPTO) has issued Notices of Allowance for three patent applications from the
company's...
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Alnylam+Pharma+%28ALNY%29+Posts+Wider+than+Expected+Q3+Loss+of+31cShare/7845526.html for the full story.
StreetInsider.com
Aug 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Monsanto+%28MON%29+and+Alnylam+Pharma+%28ALNY%29+Form+Strategic+Alliance/7688754.html for the full story.
Benzinga
Jul 16
Comment
Shares of Alnylam Pharma (NASDAQ: ALNY) were seeing increased strength during Monday's trading session after the company announced positive clinical results.
The company announced the achievement of positive clinical results from its Phase I...
StreetInsider.com
Jul 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Alnylam+Pharma+%28ALNY%29%2C+Ascletis+Pharma+Enter+ALN-VSP+Development+Collaboration/7575741.html for the full story.
StreetInsider.com
Jun 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Alnylam+Pharma+%28ALNY%29+Completes+Enrollment+in+ALN-TTR02+Phase+I%3B+Initiates+Phase+II/7500776.html for the full story.
StreetInsider.com
May 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Alnylam+Pharma+%28ALNY%29+Reports+Phase+1+Trial+Results+Show+Proof+of+Concept+for+ALN-TTR01/7422989.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
